EUVIMED · CrossrefZeitschrift
The Women's Oncology Review
ISSN 1473-3404 · Informa UK Limited
Neueste Artikel
The 'best' of the breast papers (2002) and how they affect everyday practice
Experience of the SSK (Social Security Agency) Aegean Maternity Hospital on choriocarcinomas
Cervical screening in women over the age of 50: results of a population-based multicentre study
Frequent loss of Rb2/p130 in human ovarian carcinoma
Thermochemoradiotherapy improves oxygenation in locally advanced breast cancer
Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma
Breast conservation after neoadjuvant chemotherapy: the MD Anderson Cancer Center experience
Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma
HABITS (hormonal replacement therapy after breast cancer - is it safe?), a randomized comparison: trial stopped
Breast reduction surgery and breast cancer risk: does reduction mammoplasty have a role in primary prevention strategies for women at high risk of breast cancer?
Cryoablation of early-stage breast cancer: work-in-progress. Report of a multi-institutional trial
Irradiation after immediate tissue expander/implant breast reconstruction: outcomes, complications, aesthetic results, and satisfaction among 156 patients
Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group
Impact of BRCA1 / BRCA2 counseling and testing on newly diagnosed breast cancer patients
MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer
Ductal carcinoma in situ : USC/Van Nuys Prognostic Index and the impact of margin status
VEGF and HIF-1α expression are increased in advanced stages of epithelial ovarian cancer
Editorial: Tailoring treatment to patients with early breast cancer - can we deliver?
Current issues regarding tamoxifen and the genital tract: a review
Quantitative DNA fingerprinting may distinguish new primary breast cancer from disease recurrence
Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer
Proceedings of the Consensus Conference on Neoadjuvant Chemotherapy in Carcinoma of the Breast, April 26-28, 2003, Philadelphia, Pennsylvania
Herbal remedies in the United States: potential adverse interactions with anticancer agents
Continent ileocolonic urinary reservoir (Miami pouch): the University of Miami experience over 15 years
Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations: a decision analysis
Prediction of optimal versus suboptimal cytoreduction of advanced-stage serious ovarian cancer with the use of microarrays
Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study
First case of a centropelvic recurrence after radical trachelectomy: literature review and implications for the preoperative selection of patients
Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer
The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor alpha-negative breast cancer cells to tamoxifen
EUVIMED